Form D/A — GT Biotech Fund, LP
0000905148-25-002582 · filed Jul 29, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Reported offering amount
- —
- Reported amount sold
- $229,257,953
- Minimum investment
- $16,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- GT Biotech Fund, LP
- CIK
- 1806841
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 40 S. Main Street
Memphis, Tennessee 38103 - Phone
- 901-526-9750
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
n/a Gerber/Taylor Management LLC · Executive OfficerMemphis, Tennessee Find on LinkedIn ↗
-
Michael J. Douglass · Executive OfficerMemphis, Tennessee Find on LinkedIn ↗
-
Ryan E. Gibbs · Executive OfficerMemphis, Tennessee Find on LinkedIn ↗
-
Mary C. Cornpropst · Executive OfficerMemphis, Tennessee Find on LinkedIn ↗
-
Justin L. Rikard · Executive OfficerMemphis, Tennessee Find on LinkedIn ↗
-
Simone T. Meeks · Executive OfficerMemphis, Tennessee Find on LinkedIn ↗
-
Darren Kearns · Executive OfficerMemphis, Tennessee Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗